Dexmedetomidine

• Searching for the right dose of perineural dexmedetomidine for a interscalene plexus block. Not authorised
  2023-506062-31-00 Phase III/IV 1 country Algemeen ziekenhuis Rivierenland
• Influence of Dexmedetomidine on the Human Glymphatic Cerebrospinal Fluid Flow, Neural Activity and Cerebral Blood Flow in Functional Magneti… Pending
  2023-507215-35-00 Phase II 1 country Helsinki University Central Hospital
• Pain Relief at Screening for Retinopathy of Prematurity - The PROPER study Pending
  2023-507975-23-01 Phase II 1 country St. Olavs Hospital HF
• Double blind, multicenter, randomized, controlled trial of dexmedetomidine vs placebo in premature neonates receiving invasive ventilation Pending
  2023-509247-27-00 Phase III 1 country Centre Hospitalier Intercommunal Creteil
• Impact on delirium of the use of DEXmedetomidine as first-line sedation in PEDIAtric intensive care: the PEDIADEX randomized controlled tria… Pending
  2025-521039-35-00 Phase III 1 country Centre Hospitalier Regional Universitaire De Tours
• The use of intranasal dexmedetomidine for pediatric sedation in non-invasive radiological procedures Pending
  2025-522778-34-00 Phase II 1 country Universitair Ziekenhuis Antwerpen
• Efficacy of Dexmedetomidine on Emergence Delirium in Children Undergoing Adenotonsillectomy: A Double-Blind Randomized Controlled Trial with… Pending
  2025-524086-24-00 Phase III 1 country Akershus University Hospital
• ADRESS : Efficacy of the Alpha 2 agonist dexmedetomidine for sympathetic Deactivation in REfractory Septic Shock: a randomized, controlled t… Pending
  2025-524122-18-00 Phase III 1 country Hospices Civils De Lyon
• OFA-VATS : Impact of opioid free anesthesia on postoperative quality of recovery and analgesia after video or robot assisted thoracic surger… Pending
  2025-524240-35-00 Phase III/IV 1 country Centre Hospitalier Universitaire De Rennes
• Is magnesium sulfate an alternative with an analgesic and safety profile equivalent to dexmedetomidine as an adjuvant to ropivacaine in erec… Recruiting
  2025-523152-31-00 Phase IV 1 country Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comuni…
• Intravenous Dexmedetomidine as an Adjuvant to Locoregional Anesthesia in Pediatric Surgery: A Prospective, Randomized, Double-Blind, Placebo… Recruiting
  2024-514550-73-00 Phase II 1 country Centre Hospitalier Universitaire De Montpellier
• Advancing the quality of treatment and care for acute agitation in emergency psychiatry Recruiting
  2023-510201-18-00 Phase II/III 1 country Region Hovedstaden
• Intranasal dexmedetomidine sedation and analgesia during pediatric emergency room procedures Recruiting
  2024-518816-38-00 Phase IV 1 country Oulu University Hospital
• Effects of an Opioid Sparing Care Pathway for Patients undergoing Obesity Surgery Recruiting
  2023-505934-86-00 Phase IV 1 country Vaestra Goetalandsregionen
• Alpha 2 adrenergic receptor agonists for the prevention of delirium and cognitive decline after open heart surgery (ALPHA2PREVENT): randomis… Ended
  2023-510212-39-00 Phase III/IV 1 country Oslo University Hospital HF
• The effect of nocturnal dexmedetomidine on postoperative sleep quality and fatigue after major surgery in elderly patients: DEXSLEEP study Ended
  2023-510403-22-00 Phase IV 1 country Ziekenhuis Oost Limburg
• Opioid-Free General Anesthesia Compared to Opioid-Based General Anesthesia for the Reduction of Postoperative Nausea and Vomiting in Patient… Halted
  2025-521047-20-00 Phase IV 1 country Institut De Recerca Biomedica De Lleida Fundacio Dr. Pifarre
• Searching for the right dose of perineural dexmedetomidine for a interscalene plexus block. Ended
  2023-506062-31-01 Phase III/IV 1 country Algemeen ziekenhuis Rivierenland
• Randomized Clinical Trial of Inhaled Sedation with Sevoflurane in Critically Ill Patients at Risk of Developing the Acute Respiratory Distre… Ended
  2024-517670-15-00 Phase III 1 country CHU Gabriel-Montpied
• Impact of post-Acute respiratory distress syndrome COVID sedation on late neuroinflammation (PET-DEXDOCOVID) Ended
  2024-511898-30-00 Phase III 1 country Assistance Publique Hopitaux De Paris

Showing 1–20 of 20 trials